Thomas W. Dubensky

CIK 1635590 · President · last filed 2023-01-05

Thomas W. Dubensky is a President who has filed 27 SEC Form 4 insider transactions across 3 companies since 2015. The most recent filing, for TPST, was dated Jan 5, 2023. Across all open-market trades the lifetime net is −$7.3M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $142.8K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$142.8K

Companies

3

Total Filings

27

Lifetime Open-Market Net

-$7.33M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
TPST President 113,343 $1.26 $142.8K $9.6K 5 2023-01-05
HTG MOLECULAR DIAGNOSTICS, INC (HTGM) Delisted Director $0.48 $0 1 2022-08-22
CHINOOK THERAPEUTICS, INC. (ADRO) Delisted Chief Scientific Officer 80,812 -$7.34M 21 2017-08-11

Recent Filings

27 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2023-01-05 TPST Grant (A) $0 EDGAR
2022-08-22 HTG MOLECULAR DIAGNOSTICS, INC (HTGM) Delisted Grant (A) $0 EDGAR
2022-06-22 TPST Grant (A) $0 EDGAR
2022-01-11 TPST Buy (P) +2,000 $9.6K EDGAR
2022-01-06 TPST Grant (A) $0 EDGAR
2021-06-29 TPST Grant (A) +111,343 $0 EDGAR
2017-08-11 CHINOOK THERAPEUTICS, INC. (ADRO) Delisted Mixed -$519.2K EDGAR
2017-07-06 CHINOOK THERAPEUTICS, INC. (ADRO) Delisted Mixed -$540.6K EDGAR
2017-06-14 CHINOOK THERAPEUTICS, INC. (ADRO) Delisted Grant (A) $0 EDGAR
2017-06-05 CHINOOK THERAPEUTICS, INC. (ADRO) Delisted Mixed -$1.37M EDGAR
Showing 110 of 27
Page 1 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.